Legislation to Improve Hospital Price Transparency and Medicare Practices

Legislative efforts are underway in Congress to enhance hospital price transparency, reform prescription drug policies, and oversee Medicare Advantage practices. Both the House and Senate are actively working on legislation to push for transparency and improvements in industry conduct. A recent poll by Families USA highlights the overwhelming public demand for government intervention to reduce escalating health care costs, an issue prioritized even over housing and taxes.

The Health Care Affordability Symposium in Washington, D.C., revealed bipartisan support for initiatives aimed at lowering health care expenses. Discussions at the event focused on proposals addressing hospital fee transparency, drug patent reform, and Medicare Advantage operations. The consensus among policymakers underscores the critical need for reform to improve industry transparency and accountability.

The House Energy and Commerce Committee is slated to review the Lower Cost, More Transparency Act of 2026, which mandates clear financial disclosures to bolster price transparency. Meanwhile, the Senate Health, Education, Labor, and Pensions (HELP) Committee will consider the Patients Deserve Price Tags Act, aimed at reinforcing transparency regulations. Families USA representatives, including Sophia Tripoli, underscored the urgent public demand for change, noting that 81% of Americans deem current hospital prices unreasonable. As part of the Health Care Affordability Week of Action, Families USA and other stakeholders engage with Congressional leaders to stimulate legislative movement towards resolving high health care costs.